The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

York-based Abingdon Health has announced that it has been awarded approximately £800,000 to develop a new intervention of ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

These and other major medical breakthroughs exist in large part thanks to a major division of the National Institutes of Health, the largest funder of biomedical research on the planet.

Brii said it agreed to purchase the assets from VBI Vaccines Inc. and its creditors for $18 million. The deal gives Brii full access to the remaining IP, patents and materials related to BRII-179, an ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

A systematic review of existing medicines has found that antibiotics and vaccinations are associated with a reduced risk of dementia. Across the 14 studies included in the data crunch, most of which ...

The FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for the treatment of chronic hepatitis delta, for which no approved therapies currently exist in the U.S., the ...

On today’s CT Buzz, Host Natasha Lubczenko welcomed Dr. Housein Wazaz, MD, a Gastroenterologist from MidState ...